How Pharma Is Tightening Its Supply Chain To Avoid Counterfeiting.

Focuses on the actions taken by pharmaceutical companies to avoid counterfeit medications in the U.S. Increase in counterfeit investigations from 1990 to 2003; Losses incurred by the pharmaceutical industry in 2003 brought by counterfeit medications; Information on the radio frequency identification systems selected by the U.S. Food and Drug Administration for mass serialization in the industry. INSET: Johnson & Johnson Secures Its Supply Chain.